Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: This case was reported by a physician via a GSK representative and described the occurrence of invagination of intestine in a 13 month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Medical condition was unspecified. First dose of ROTARIX was given in December 2007. In January 2008, the subject received a 2nd dose of ROTARIX (oral, batch not available). On 28 November 2008, 10 months after the second vaccination with ROTARIX, the subject developed invagination of intestine, confirmed by unspecified investigations. The subject was treated with barium salt and event resolved without sequelae. This case was assessed as medically serious by GSK. The physician considered the event was unrelated to vaccination with ROTARIX.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166